Adverse events13

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 13 of 13

Type	Event	Organ system	Group	Affected	At risk	Events
other	Oedema peripheral	General disorders	Nemolizumab	1	18
other	Fatigue	General disorders	Nemolizumab	1	18
other	Bronchitis	Infections and infestations	Nemolizumab	1	18
other	Rash pustular	Infections and infestations	Nemolizumab	1	18
other	Upper respiratory tract infection	Infections and infestations	Nemolizumab	1	18
other	Arthropod bite	Injury, poisoning and procedural complications	Nemolizumab	1	18
other	Blood creatine phosphokinase increased	Investigations	Nemolizumab	1	18
other	Pain in extremity	Musculoskeletal and connective tissue disorders	Nemolizumab	1	18
other	Depression	Psychiatric disorders	Nemolizumab	1	18
other	Dermatitis atopic	Skin and subcutaneous tissue disorders	Nemolizumab	1	18
serious	Oedema peripheral	General disorders	Nemolizumab	1	18	1
serious	Eczema infected	Infections and infestations	Nemolizumab	1	18	1
serious	Staphylococcus skin infection	Infections and infestations	Nemolizumab	1	18	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03921411/events